Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release

BACKGROUND: Treatment multiple tumors by immune therapy can be achieved by mobilizing both innate and adaptive immunity. The programmed death ligand 1 (PD-L1; or CD274, B7-H1) is a critical “don't find me” signal to the adaptive immune system. Equally CD47 is a critical “don't eat me” sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Shu, Xie, Ruizhi, Ye, Yuying, Xie, Xiaodong, Li, Shuhui, Lu, Yusheng, Li, Bifei, Cheng, Yunlong, Katanaev, Vladimir L., Jia, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491392/
https://www.ncbi.nlm.nih.gov/pubmed/30878596
http://dx.doi.org/10.1016/j.ebiom.2019.03.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491392/
https://www.ncbi.nlm.nih.gov/pubmed/30878596
http://dx.doi.org/10.1016/j.ebiom.2019.03.018

Ejemplares similares